Funding news
LIVZYM BIOTECHNOLOGIES logo

LIVZYM BIOTECHNOLOGIES Raises

Recently funded · $11.0M Series aTechnology, Information and MediaTRView source

Get the full LIVZYM BIOTECHNOLOGIES company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Precision fermentation specialist LIVZYM BIOTECHNOLOGIES has closed its Series A funding round, securing $11.0M to advance its work in microbial engineering and large-scale enzyme production. The company, which has been developing sustainable, high-impact solutions since 2014, focuses on creating environmentally friendly, scalable products tailored to diverse industrial needs.

LIVZYM's core business involves producing high-performance enzymes, leveraging cutting-edge biotechnology to power a wide range of industries with efficiency and sustainability. They also excel in scaling fermentation from lab to large-scale production, offering end-to-end services including strain development, scale-up, and CDMO/CMO solutions.

Other Turkey companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Luffy AI logo

Luffy AI

United Kingdom

$10.2M
2
LEKO logo

LEKO

Luxembourg

$32.1M
3
Nouu (SUP´25) logo

Nouu (SUP´25)

$33.0K
4
Nami Energy logo

Nami Energy

Vietnam

$10.0M
5
TeamSec logo

TeamSec

Turkey

$5.1M